American Pharmaceutical Partners Inc. A securities class action lawsuit brought against the company has been dropped. The plaintiffs originally sought compensation for false and misleading information regarding financial statements about Abraxane, a breast cancer treatment medication. The class included investors who purchased American Pharmaceutical Partners' stock from Feb. 19, 2002, to Oct. 6, 2003. (Mar-14-05)
[FORBES]
Stay Informed
Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.
Get our Newsletter!
Submit a New Complaint
Been wronged by a similar product or service?
Click here to send us your complaint.
